Xtandi (enzalutamide) Disease area(s): Oncology Manufacturer(s): Astellas/Pfizer 2024 Sales (USD): $7.94 billion Why it sold so well: In 2024, Astellas Pharmas Xtandi, co-marketed with Pfizer, posted strong sales growth, with revenues reaching 703.1 billion ($4.64 billion) for the first nine months (April 1, 2024 to December 31, 2024), marking a 25.6% increase compared to the same period in the previous year
antiaglomerantes: talco, estearato de magnesio, celulosa
Content: 100 Vegan Capsules (0.20* / 1 Vegan Capsules) Top Seller #24 Average rating of 0 out of 5 stars Applied Nutrition CLA L-Carnitine Green Tea 100 Softgels Applied Nutrition CLA L-Carnitine Green Tea 100 Softgels is an advanced dietary supplement expertly formulated to support fat metabolism, energy production, and effective weight management
Diabetes 55 , 23012310 (2006)
PubMed PMID: 10885050